Daniel from Norway

Registered at the short selling broker Pepperstone, 3 minutes ago.

» Try Pepperstone you too
78.6% of retail investor accounts lose money when trading spread bets and CFDs with Pepperstone.
Don't show again

CARA Therapeutics, Inc. (CARA) shares information

Cara Therapeutics Inc

24h Change

1.08 %


Live rate: Market closed

Stock data per Friday 25 Nov, 2022

0.12 (+ 1.08%)
US Market is closed

Live Stock price in graph for Cara Therapeutics Inc (CARA)

  • Latest Volume

    119,583 (-32.45 %)

  • Volume prev. day


  • Avg. daily volume


  • Market cap


  • P/E ratio


  • Today high

    11.21 USD

  • Today low

    10.74 USD

  • 52 week high

    13.97 USD

  • 52 week low

    7.4 USD

  • YTD Change


Quick links


Latest news about Cara Therapeutics Inc

Below you can find the most recent news posts about Cara Therapeutics Inc, primarily from US and UK based news sources.

Neutral On Cara Therapeutics Stock (NASDAQ:CARA)

Saturday, 26 November 2022, 07:32:38
I like the capital structure of Cara Therapeutics, but the company seems incapable of turning a profit. See why I”m neutral on CARA stock.
— Seeking Alpha

Cara Therapeutics Inc (CARA) Q3 2022 Earnings Call Transcript | AlphaStreet

Tuesday, 8 November 2022, 03:18:37
Cara Therapeutics Inc (NASDAQ:CARA) Q3 2022 Earnings Call dated Nov. 07, 2022.
— AlphaStreet

Cara Therapeutics, Inc. (CARA) Q3 2022 Earnings Call Transcript

Tuesday, 8 November 2022, 02:31:01
Cara Therapeutics, Inc. (NASDAQ:NASDAQ:CARA) Q3 2022 Earnings Conference Call November 07, 2022, 16:30 ET Company Participants Matthew Murphy – Manager, Investor Relations Christopher…
— Seeking Alpha

Cara Therapeutics GAAP EPS of -$0.43 beats by $0.01, revenue of $10.81M beats by $1.95M (NASDAQ:CARA)

Monday, 7 November 2022, 22:04:00
Cara Therapeutics press release (NASDAQ:CARA): Q3 GAAP EPS of -$0.43 beats by $0.01.Revenue of $10.81M (-46.7% Y/Y) beats by $1.95M.
— Seeking Alpha

Cara Therapeutics Reports Third Quarter 2022 Financial Results

Monday, 7 November 2022, 22:01:00
– Net revenue was $16.2M for 3Q22 including profit-sharing revenue of $7.4M from KORSUVA ® (difelikefalin) injection –
— GlobeNewswire

Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have CARA available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.